O	O	0	10	Modulation	Modulation	B-NP	NN	O	0	ROOT	O
O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
O	O	14	18	mRNA	mRNA	B-NP	NN	B-RNA	4	NMOD	B-RNA
O	O	19	29	expression	expression	I-NP	NN	O	2	PMOD	O
O	O	30	32	of	of	B-PP	IN	O	4	NMOD	O
O	O	33	34	a	a	B-NP	DT	O	5	PMOD	O
O	O	35	40	novel	novel	I-NP	JJ	O	6	PRD	O
O	O	41	46	human	human	I-NP	JJ	O	7	AMOD	O
O	O	47	54	myeloid	myeloid	I-NP	JJ	O	8	AMOD	O
O	O	54	55	-	-	I-NP	HYPH	O	9	AMOD	O
O	O	55	64	selective	selective	I-NP	JJ	O	10	PRD	O
T1	B-Protein	65	70	CCAAT	CCAAT	I-NP	NN	O	11	AMOD	O
T1	I-Protein	70	71	/	/	B-VP	SYM	O	12	NMOD	O
T1	I-Protein	71	79	enhancer	enhancer	B-NP	NN	B-DNA	17	NMOD	B-DNA
T1	I-Protein	80	87	binding	binding	I-NP	NN	I-DNA	17	NMOD	I-DNA
T1	I-Protein	88	95	protein	protein	I-NP	NN	I-DNA	17	NMOD	I-DNA
O	O	96	100	gene	gene	I-NP	NN	I-DNA	13	PMOD	I-DNA
O	O	101	102	(	(	O	(	O	23	DEP	O
T2	B-Protein	102	103	C	C	B-NP	NN	B-DNA	22	NMOD	B-DNA
T2	I-Protein	103	104	/	/	O	SYM	I-DNA	22	P	I-DNA
T2	I-Protein	104	107	EBP	EBP	B-NP	NN	I-DNA	22	NMOD	I-DNA
T2	I-Protein	108	115	epsilon	epsilon	I-NP	NN	I-DNA	23	DEP	I-DNA
O	O	115	116	)	)	O	)	O	17	NMOD	O
O	O	116	117	.	.	O	.	O	1	P	O

O	O	119	124	Human	Human	B-NP	JJ	B-DNA	5	NMOD	B-DNA
T3	B-Protein	125	126	C	C	I-NP	NN	I-DNA	5	NMOD	I-DNA
T3	I-Protein	126	127	/	/	B-VP	SYM	I-DNA	5	NMOD	I-DNA
T3	I-Protein	127	130	EBP	EBP	B-NP	NN	I-DNA	5	NMOD	I-DNA
T3	I-Protein	131	138	epsilon	epsilon	I-NP	NN	I-DNA	6	SUB	I-DNA
O	O	139	141	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	142	143	a	a	B-NP	DT	O	10	NMOD	O
O	O	144	149	newly	newly	I-NP	RB	O	9	AMOD	O
O	O	150	156	cloned	clone	I-NP	VBN	O	10	NMOD	O
O	O	157	161	gene	gene	I-NP	NN	O	6	PRD	O
O	O	162	168	coding	cod	B-VP	VBG	O	10	NMOD	O
O	O	169	172	for	for	B-PP	IN	O	11	VMOD	O
O	O	173	174	a	a	B-NP	DT	O	18	NMOD	O
T4	B-Protein	175	180	CCAAT	CCAAT	I-NP	NN	B-protein	18	NMOD	B-protein
T4	I-Protein	180	181	/	/	O	SYM	I-protein	18	P	I-protein
T4	I-Protein	181	189	enhancer	enhancer	B-NP	NN	I-protein	18	NMOD	I-protein
T4	I-Protein	190	197	binding	binding	I-NP	NN	I-protein	18	NMOD	I-protein
T4	I-Protein	198	205	protein	protein	I-NP	NN	I-protein	12	PMOD	I-protein
O	O	206	210	that	that	B-NP	WDT	O	18	NMOD	O
O	O	211	214	may	may	B-VP	MD	O	19	SBAR	O
O	O	215	217	be	be	I-VP	VB	O	20	VC	O
O	O	218	226	involved	involve	I-VP	VBN	O	21	VC	O
O	O	227	229	in	in	B-PP	IN	O	22	VMOD	O
O	O	230	233	the	the	B-NP	DT	O	25	NMOD	O
O	O	234	244	regulation	regulation	I-NP	NN	O	23	PMOD	O
O	O	245	247	of	of	B-PP	IN	O	25	NMOD	O
O	O	248	255	myeloid	myeloid	B-NP	JJ	O	28	NMOD	O
O	O	256	271	differentiation	differentiation	I-NP	NN	O	26	PMOD	O
O	O	271	272	.	.	O	.	O	6	P	O

O	O	273	276	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	277	284	studies	study	I-NP	NNS	O	3	SUB	O
O	O	285	291	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	292	296	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	297	303	levels	level	B-NP	NNS	O	12	SUB	O
O	O	304	306	of	of	B-PP	IN	O	5	NMOD	O
T5	B-Protein	307	308	C	C	B-NP	NN	B-RNA	11	NMOD	B-RNA
T5	I-Protein	308	309	/	/	B-NP	SYM	I-RNA	11	NMOD	I-RNA
T5	I-Protein	309	312	EBP	EBP	I-NP	NN	I-RNA	11	NMOD	I-RNA
T5	I-Protein	313	320	epsilon	epsilon	I-NP	NN	I-RNA	11	NMOD	I-RNA
O	O	321	325	mRNA	mRNA	I-NP	NN	I-RNA	6	PMOD	I-RNA
O	O	326	330	were	be	B-VP	VBD	O	4	SBAR	O
O	O	331	339	markedly	markedly	I-VP	RB	O	12	VMOD	O
O	O	340	349	increased	increase	I-VP	VBN	O	12	VC	O
O	O	350	352	in	in	B-PP	IN	O	14	VMOD	O
O	O	353	356	NB4	NB4	B-NP	NN	B-cell_line	17	NMOD	B-cell_line
O	O	357	362	cells	cell	I-NP	NNS	I-cell_line	15	PMOD	I-cell_line
O	O	363	364	(	(	O	(	O	22	DEP	O
O	O	364	377	promyelocytic	promyelocytic	B-NP	JJ	B-cell_line	21	NMOD	B-cell_line
O	O	378	386	leukemia	leukemia	I-NP	NN	I-cell_line	21	NMOD	I-cell_line
O	O	387	391	line	line	I-NP	NN	I-cell_line	22	DEP	I-cell_line
O	O	391	392	)	)	O	)	O	17	NMOD	O
O	O	392	393	,	,	O	,	O	12	P	O
O	O	394	401	because	because	B-SBAR	IN	O	12	VMOD	O
O	O	402	406	they	they	B-NP	PRP	O	26	SUB	O
O	O	407	411	were	be	B-VP	VBD	O	24	SBAR	O
O	O	412	419	induced	induce	I-VP	VBN	O	26	VC	O
O	O	420	422	by	by	B-PP	IN	O	27	VMOD	O
O	O	423	424	9	9	B-NP	CD	O	33	NMOD	O
O	O	424	425	-	-	I-NP	HYPH	O	33	NMOD	O
O	O	425	428	cis	cis	I-NP	NN	O	33	NMOD	O
O	O	429	437	retinoic	retinoic	I-NP	JJ	O	33	NMOD	O
O	O	438	442	acid	acid	I-NP	NN	O	28	PMOD	O
O	O	443	444	(	(	O	(	O	39	DEP	O
O	O	444	445	9	9	B-NP	CD	O	38	NMOD	O
O	O	445	446	-	-	I-NP	HYPH	O	38	NMOD	O
O	O	446	449	cis	cis	I-NP	NN	O	38	NMOD	O
O	O	450	452	RA	RA	I-NP	NN	O	39	DEP	O
O	O	452	453	)	)	O	)	O	33	NMOD	O
O	O	454	456	to	to	B-VP	TO	O	41	VMOD	O
O	O	457	470	differentiate	differentiate	I-VP	VB	O	27	VMOD	O
O	O	471	478	towards	towards	B-PP	IN	O	41	VMOD	O
O	O	479	491	granulocytes	granulocyte	B-NP	NNS	B-cell_type	42	PMOD	B-cell_type
O	O	491	492	.	.	O	.	O	3	P	O

O	O	493	505	Accumulation	Accumulation	B-NP	NN	O	8	SUB	O
O	O	506	508	of	of	B-PP	IN	O	1	NMOD	O
T6	B-Protein	509	510	C	C	B-NP	NN	B-RNA	7	NMOD	B-RNA
T6	I-Protein	510	511	/	/	B-NP	SYM	I-RNA	7	NMOD	I-RNA
T6	I-Protein	511	514	EBP	EBP	I-NP	NN	I-RNA	7	NMOD	I-RNA
T6	I-Protein	515	522	epsilon	epsilon	I-NP	NN	I-RNA	7	NMOD	I-RNA
O	O	523	527	mRNA	mRNA	I-NP	NN	I-RNA	2	PMOD	I-RNA
O	O	528	536	occurred	occur	B-VP	VBD	O	43	VMOD	O
O	O	537	539	as	as	B-ADVP	RB	O	8	VMOD	O
O	O	540	545	early	early	I-ADVP	RB	O	9	AMOD	O
O	O	546	548	as	as	B-PP	IN	O	9	AMOD	O
O	O	549	550	1	1	B-NP	CD	O	13	NMOD	O
O	O	551	555	hour	hour	I-NP	NN	O	14	PMOD	O
O	O	556	561	after	after	B-PP	IN	O	11	PMOD	O
O	O	562	570	exposure	exposure	B-NP	NN	O	14	PMOD	O
O	O	571	573	of	of	B-PP	IN	O	15	NMOD	O
O	O	574	577	NB4	NB4	B-NP	NN	B-cell_line	18	NMOD	B-cell_line
O	O	578	583	cells	cell	I-NP	NNS	I-cell_line	16	PMOD	I-cell_line
O	O	584	586	to	to	B-PP	TO	O	15	NMOD	O
O	O	587	588	9	9	B-NP	CD	O	23	NMOD	O
O	O	588	589	-	-	I-NP	HYPH	O	23	NMOD	O
O	O	589	592	cis	cis	I-NP	NN	O	23	NMOD	O
O	O	593	595	RA	RA	I-NP	NN	O	34	NMOD	O
O	O	596	597	(	(	O	(	O	31	DEP	O
O	O	597	598	5	5	B-NP	CD	O	26	NMOD	O
O	O	599	600	x	x	I-NP	NN	O	31	DEP	O
O	O	601	603	10	10	I-NP	CD	O	26	NMOD	O
O	O	603	604	(	(	O	(	O	31	DEP	O
O	O	604	605	-	-	O	SYM	O	31	DEP	O
O	O	605	606	7	7	O	CD	O	29	PRD	O
O	O	606	607	)	)	O	)	O	23	NMOD	O
O	O	608	611	mol	mol	B-NP	NN	O	34	NMOD	O
O	O	611	612	/	/	B-NP	SYM	O	34	NMOD	O
O	O	612	613	L	L	I-NP	NN	O	19	PMOD	O
O	O	613	614	)	)	O	)	O	15	NMOD	O
O	O	614	615	;	;	O	:	O	43	P	O
O	O	616	619	and	and	O	CC	O	43	VMOD	O
O	O	620	622	at	at	B-PP	IN	O	43	VMOD	O
O	O	623	625	48	48	B-NP	CD	O	40	NMOD	O
O	O	626	631	hours	hour	I-NP	NNS	O	38	PMOD	O
O	O	631	632	,	,	O	,	O	43	P	O
O	O	633	639	levels	level	B-NP	NNS	O	43	SUB	O
O	O	640	644	were	be	B-VP	VBD	O	0	ROOT	O
O	O	645	654	increased	increase	I-VP	VBN	O	43	VC	O
O	O	655	657	by	by	B-PP	IN	O	44	VMOD	O
O	O	658	659	5	5	B-NP	CD	O	49	NMOD	O
O	O	659	660	.	.	O	.	O	46	P	O
O	O	660	661	1	1	B-NP	CD	O	46	NMOD	O
O	O	661	662	-	-	O	HYPH	O	45	P	O
O	O	662	666	fold	fold	B-ADVP	RB	O	45	PMOD	O
O	O	666	667	.	.	O	.	O	43	P	O

O	O	668	672	Dose	Dose	B-NP	NN	O	4	NMOD	O
O	O	672	673	-	-	I-NP	HYPH	O	4	NMOD	O
O	O	673	681	response	response	I-NP	NN	O	4	NMOD	O
O	O	682	689	studies	study	I-NP	NNS	O	5	SUB	O
O	O	690	696	showed	show	B-VP	VBD	O	54	VMOD	O
O	O	697	701	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	702	704	10	10	B-NP	CD	O	13	AMOD	O
O	O	704	705	(	(	O	(	O	11	DEP	O
O	O	705	706	-	-	O	SYM	O	11	DEP	O
O	O	706	707	7	7	B-NP	CD	O	9	PRD	O
O	O	707	708	)	)	O	)	O	7	NMOD	O
O	O	709	711	to	to	B-PP	TO	O	13	AMOD	O
O	O	712	714	10	10	B-NP	CD	O	24	NMOD	O
O	O	714	715	(	(	O	(	O	17	DEP	O
O	O	715	716	-	-	O	SYM	O	17	DEP	O
O	O	716	717	6	6	O	CD	O	15	PRD	O
O	O	717	718	)	)	O	)	O	13	NMOD	O
O	O	719	722	mol	mol	B-NP	NN	O	24	NMOD	O
O	O	722	723	/	/	B-VP	SYM	O	24	NMOD	O
O	O	723	724	L	L	B-NP	NN	B-protein	24	NMOD	B-protein
O	O	725	726	9	9	I-NP	CD	I-protein	20	NMOD	I-protein
O	O	726	727	-	-	I-NP	HYPH	O	24	NMOD	O
O	O	727	730	cis	cis	I-NP	NN	O	24	NMOD	O
O	O	731	733	RA	RA	I-NP	NN	O	29	SUB	O
O	O	734	735	(	(	O	(	O	28	DEP	O
O	O	735	737	12	12	B-NP	CD	O	27	NMOD	O
O	O	738	743	hours	hour	I-NP	NNS	O	28	DEP	O
O	O	743	744	)	)	O	)	O	24	NMOD	O
O	O	745	753	resulted	result	B-VP	VBD	O	6	SBAR	O
O	O	754	756	in	in	B-PP	IN	O	29	VMOD	O
O	O	757	761	peak	peak	B-NP	NN	O	32	NMOD	O
O	O	762	768	levels	level	I-NP	NNS	O	30	PMOD	O
O	O	769	771	of	of	B-PP	IN	O	32	NMOD	O
T7	B-Protein	772	773	C	C	B-NP	NN	B-RNA	38	NMOD	B-RNA
T7	I-Protein	773	774	/	/	B-NP	SYM	I-RNA	38	P	I-RNA
T7	I-Protein	774	777	EBP	EBP	I-NP	NN	I-RNA	38	NMOD	I-RNA
T7	I-Protein	778	785	epsilon	epsilon	I-NP	NN	I-RNA	38	NMOD	I-RNA
O	O	786	790	mRNA	mRNA	I-NP	NN	I-RNA	33	PMOD	I-RNA
O	O	790	791	;	;	O	:	O	54	P	O
O	O	792	795	but	but	O	CC	O	54	VMOD	O
O	O	796	800	even	even	B-NP	RB	O	42	NMOD	O
O	O	801	803	10	10	I-NP	CD	O	54	SUB	O
O	O	803	804	(	(	O	(	O	46	DEP	O
O	O	804	805	-	-	O	SYM	O	46	DEP	O
O	O	805	807	10	10	O	CD	O	44	PRD	O
O	O	807	808	)	)	O	)	O	42	NMOD	O
O	O	809	812	mol	mol	B-NP	NN	O	54	SUB	O
O	O	812	813	/	/	B-VP	SYM	O	47	NMOD	O
O	O	813	814	L	L	B-NP	NN	B-protein	53	NMOD	B-protein
O	O	815	816	9	9	I-NP	CD	I-protein	49	NMOD	I-protein
O	O	816	817	-	-	I-NP	HYPH	O	53	NMOD	O
O	O	817	820	cis	cis	I-NP	NN	O	53	NMOD	O
O	O	821	823	RA	RA	I-NP	NN	O	48	PMOD	O
O	O	824	833	increased	increase	B-VP	VBD	O	0	ROOT	O
O	O	834	840	levels	level	B-NP	NNS	O	54	OBJ	O
O	O	841	843	of	of	B-PP	IN	O	55	NMOD	O
O	O	844	849	these	these	B-NP	DT	O	58	NMOD	O
O	O	850	861	transcripts	transcript	I-NP	NNS	O	56	PMOD	O
O	O	861	862	.	.	O	.	O	54	P	O

O	O	863	866	NB4	NB4	B-NP	NN	O	3	NMOD	O
O	O	867	872	cells	cell	I-NP	NNS	O	3	NMOD	O
O	O	873	878	pulse	pulse	I-NP	NN	O	40	SUB	O
O	O	878	879	-	-	O	HYPH	O	3	P	O
O	O	879	886	exposed	expose	B-VP	VBN	O	3	NMOD	O
O	O	887	888	(	(	O	(	O	9	DEP	O
O	O	888	890	30	30	B-NP	CD	O	8	NMOD	O
O	O	891	898	minutes	minute	I-NP	NNS	O	9	DEP	O
O	O	898	899	)	)	O	)	O	5	VMOD	O
O	O	900	902	to	to	B-PP	TO	O	5	VMOD	O
O	O	903	906	all	all	B-NP	RB	O	15	NMOD	O
O	O	906	907	-	-	I-NP	HYPH	O	11	AMOD	O
O	O	907	912	trans	trans	I-NP	JJ	O	11	AMOD	O
O	O	913	921	retinoic	retinoic	I-NP	JJ	O	15	NMOD	O
O	O	922	926	acid	acid	I-NP	NN	O	10	PMOD	O
O	O	927	928	(	(	O	(	O	18	DEP	O
O	O	928	932	ATRA	ATRA	B-NP	NN	O	18	DEP	O
O	O	932	933	)	)	O	)	O	15	NMOD	O
O	O	933	934	,	,	O	,	O	5	P	O
O	O	935	941	washed	wash	B-VP	VBN	O	5	VMOD	O
O	O	941	942	,	,	O	,	O	3	P	O
O	O	943	946	and	and	O	CC	O	40	VMOD	O
O	O	947	955	cultured	culture	B-VP	VBN	O	40	VMOD	O
O	O	956	957	(	(	O	(	O	27	DEP	O
O	O	957	958	3	3	B-NP	CD	O	26	NMOD	O
O	O	959	963	days	day	I-NP	NNS	O	27	DEP	O
O	O	963	964	)	)	O	)	O	23	VMOD	O
O	O	965	969	with	with	B-PP	IN	O	23	VMOD	O
O	O	970	976	either	either	O	CC	O	36	NMOD	O
O	O	977	994	dimethylsulfoxide	dimethylsulfoxide	B-NP	NN	O	36	NMOD	O
O	O	995	996	(	(	O	(	O	33	DEP	O
O	O	996	1000	DMSO	DMSO	B-NP	NN	O	33	DEP	O
O	O	1000	1001	)	)	O	)	O	30	NMOD	O
O	O	1002	1004	or	or	O	CC	O	36	NMOD	O
O	O	1005	1018	hexamethylene	hexamethylene	B-NP	NN	O	36	NMOD	O
O	O	1019	1031	bisacetamide	bisacetamide	I-NP	NN	O	28	PMOD	O
O	O	1032	1033	(	(	O	(	O	39	DEP	O
O	O	1033	1037	HMBA	HMBA	B-NP	NN	O	39	DEP	O
O	O	1037	1038	)	)	O	)	O	36	NMOD	O
O	O	1039	1042	had	have	B-VP	VBD	O	67	VMOD	O
O	O	1043	1044	a	a	B-NP	DT	O	43	NMOD	O
O	O	1045	1054	prominent	prominent	I-NP	JJ	O	43	NMOD	O
O	O	1055	1063	increase	increase	I-NP	NN	O	40	OBJ	O
O	O	1064	1066	in	in	B-PP	IN	O	40	VMOD	O
O	O	1067	1073	levels	level	B-NP	NNS	O	44	PMOD	O
O	O	1074	1076	of	of	B-PP	IN	O	45	NMOD	O
T8	B-Protein	1077	1078	C	C	B-NP	NN	B-RNA	51	NMOD	B-RNA
T8	I-Protein	1078	1079	/	/	B-NP	SYM	I-RNA	51	NMOD	I-RNA
T8	I-Protein	1079	1082	EBP	EBP	I-NP	NN	I-RNA	51	NMOD	I-RNA
T8	I-Protein	1083	1090	epsilon	epsilon	I-NP	NN	I-RNA	51	NMOD	I-RNA
O	O	1091	1095	mRNA	mRNA	I-NP	NN	I-RNA	46	PMOD	I-RNA
O	O	1096	1099	and	and	O	CC	O	67	VMOD	O
O	O	1100	1102	an	an	B-NP	DT	O	54	NMOD	O
O	O	1103	1111	increase	increase	I-NP	NN	O	67	SUB	O
O	O	1112	1114	in	in	B-PP	IN	O	54	NMOD	O
O	O	1115	1127	granulocytic	granulocytic	B-NP	JJ	O	57	NMOD	O
O	O	1128	1143	differentiation	differentiation	I-NP	NN	O	55	PMOD	O
O	O	1143	1144	,	,	O	,	O	67	P	O
O	O	1145	1148	but	but	O	CC	O	67	VMOD	O
O	O	1149	1157	exposure	exposure	B-NP	NN	O	67	SUB	O
O	O	1158	1160	to	to	B-PP	TO	O	60	NMOD	O
O	O	1161	1167	either	either	O	CC	O	65	NMOD	O
O	O	1168	1172	DMSO	DMSO	B-NP	NN	O	65	NMOD	O
O	O	1173	1175	or	or	I-NP	CC	O	65	NMOD	O
O	O	1176	1180	HMBA	HMBA	I-NP	NN	B-protein	61	PMOD	B-protein
O	O	1181	1186	alone	alone	B-ADVP	RB	O	65	NMOD	O
O	O	1187	1190	had	have	B-VP	VBD	O	0	ROOT	O
O	O	1191	1193	no	no	B-NP	DT	O	69	NMOD	O
O	O	1194	1200	effect	effect	I-NP	NN	O	67	OBJ	O
O	O	1201	1203	on	on	B-PP	IN	O	67	VMOD	O
O	O	1204	1208	base	base	B-NP	NN	O	72	NMOD	O
O	O	1209	1215	levels	level	I-NP	NNS	O	70	PMOD	O
O	O	1216	1218	of	of	B-PP	IN	O	72	NMOD	O
T9	B-Protein	1219	1220	C	C	B-NP	NN	B-protein	77	NMOD	B-protein
T9	I-Protein	1220	1221	/	/	O	SYM	I-protein	77	NMOD	I-protein
T9	I-Protein	1221	1224	EBP	EBP	B-NP	NN	I-protein	77	NMOD	I-protein
T9	I-Protein	1225	1232	epsilon	epsilon	I-NP	NN	I-protein	73	PMOD	I-protein
O	O	1233	1236	and	and	O	CC	O	67	VMOD	O
O	O	1237	1240	did	do	B-VP	VBD	O	67	VMOD	O
O	O	1241	1244	not	not	I-VP	RB	O	79	VMOD	O
O	O	1245	1251	induce	induce	I-VP	VB	O	79	VC	O
O	O	1252	1267	differentiation	differentiation	B-NP	NN	O	81	OBJ	O
O	O	1267	1268	.	.	O	.	O	67	P	O

O	O	1269	1279	Macrophage	Macrophage	B-NP	NN	B-cell_type	3	NMOD	B-cell_type
O	O	1279	1280	-	-	I-NP	HYPH	O	3	P	O
O	O	1280	1295	differentiation	differentiation	I-NP	NN	O	6	SUB	O
O	O	1296	1298	of	of	B-PP	IN	O	3	NMOD	O
O	O	1299	1302	NB4	NB4	B-NP	NN	B-cell_line	4	PMOD	B-cell_line
O	O	1303	1310	reduced	reduce	B-VP	VBD	O	0	ROOT	O
O	O	1311	1317	levels	level	B-NP	NNS	O	6	OBJ	O
O	O	1318	1320	of	of	B-PP	IN	O	7	NMOD	O
T10	B-Protein	1321	1322	C	C	B-NP	NN	B-RNA	13	NMOD	B-RNA
T10	I-Protein	1322	1323	/	/	B-NP	SYM	I-RNA	13	NMOD	I-RNA
T10	I-Protein	1323	1326	EBP	EBP	I-NP	NN	I-RNA	13	NMOD	I-RNA
T10	I-Protein	1327	1334	epsilon	epsilon	I-NP	NN	I-RNA	13	NMOD	I-RNA
O	O	1335	1339	mRNA	mRNA	I-NP	NN	I-RNA	8	PMOD	I-RNA
O	O	1339	1340	.	.	O	.	O	6	P	O

O	O	1341	1348	Nuclear	Nuclear	B-NP	JJ	O	11	SUB	O
O	O	1349	1352	run	run	B-VP	VB	O	11	VMOD	O
O	O	1352	1353	-	-	B-ADVP	HYPH	O	11	P	O
O	O	1353	1356	off	off	B-PRT	RP	O	3	VMOD	O
O	O	1357	1363	assays	assay	B-NP	NNS	O	10	NMOD	O
O	O	1364	1367	and	and	O	CC	O	10	NMOD	O
O	O	1368	1372	half	half	B-NP	JJ	O	10	NMOD	O
O	O	1372	1373	-	-	I-NP	HYPH	O	10	NMOD	O
O	O	1373	1377	life	life	I-NP	NN	O	10	NMOD	O
O	O	1378	1385	studies	study	I-NP	NNS	O	11	SUB	O
O	O	1386	1392	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	1393	1397	that	that	B-SBAR	IN	O	11	VMOD	O
O	O	1398	1410	accumulation	accumulation	B-NP	NN	O	25	SUB	O
O	O	1411	1413	of	of	B-PP	IN	O	13	NMOD	O
T11	B-Protein	1414	1415	C	C	B-NP	NN	B-RNA	19	NMOD	B-RNA
T11	I-Protein	1415	1416	/	/	O	SYM	I-RNA	19	P	I-RNA
T11	I-Protein	1416	1419	EBP	EBP	B-NP	NN	I-RNA	19	NMOD	I-RNA
T11	I-Protein	1420	1427	epsilon	epsilon	I-NP	NN	I-RNA	19	NMOD	I-RNA
O	O	1428	1432	mRNA	mRNA	I-NP	NN	I-RNA	14	PMOD	I-RNA
O	O	1433	1435	by	by	B-PP	IN	O	13	NMOD	O
O	O	1436	1437	9	9	B-NP	CD	O	24	NMOD	O
O	O	1437	1438	-	-	I-NP	HYPH	O	24	NMOD	O
O	O	1438	1441	cis	cis	I-NP	NN	O	24	NMOD	O
O	O	1442	1444	RA	RA	I-NP	NN	O	20	PMOD	O
O	O	1445	1448	was	be	B-VP	VBD	O	12	SBAR	O
O	O	1449	1452	due	due	B-ADJP	JJ	O	25	PRD	O
O	O	1453	1455	to	to	B-PP	TO	O	26	AMOD	O
O	O	1456	1464	enhanced	enhance	B-NP	VBN	O	29	NMOD	O
O	O	1465	1478	transcription	transcription	I-NP	NN	O	27	PMOD	O
O	O	1478	1479	.	.	O	.	O	11	P	O

O	O	1480	1491	Furthermore	Furthermore	B-ADVP	RB	O	10	VMOD	O
O	O	1491	1492	,	,	O	,	O	10	P	O
O	O	1493	1497	this	this	B-NP	DT	O	9	NMOD	O
T12	B-Protein	1498	1499	C	C	I-NP	NN	O	9	NMOD	O
T12	I-Protein	1499	1500	/	/	B-VP	SYM	O	9	NMOD	O
T12	I-Protein	1500	1503	EBP	EBP	B-NP	NN	B-RNA	9	NMOD	B-RNA
T12	I-Protein	1504	1511	epsilon	epsilon	I-NP	NN	I-RNA	9	NMOD	I-RNA
O	O	1512	1516	mRNA	mRNA	I-NP	NN	I-RNA	9	NMOD	I-RNA
O	O	1517	1529	accumulation	accumulation	I-NP	NN	O	10	SUB	O
O	O	1530	1533	did	do	B-VP	VBD	O	0	ROOT	O
O	O	1534	1537	not	not	I-VP	RB	O	10	VMOD	O
O	O	1538	1545	require	require	I-VP	VB	O	10	VC	O
O	O	1546	1555	synthesis	synthesis	B-NP	NN	O	12	OBJ	O
O	O	1556	1558	of	of	B-PP	IN	O	13	NMOD	O
O	O	1559	1562	new	new	B-NP	JJ	O	14	PMOD	O
O	O	1563	1570	protein	protein	I-NP	NN	B-protein	17	NMOD	B-protein
O	O	1571	1578	factors	factor	I-NP	NNS	I-protein	15	NMOD	I-protein
O	O	1579	1586	because	because	B-SBAR	IN	O	10	VMOD	O
O	O	1587	1588	9	9	B-NP	CD	O	22	NMOD	O
O	O	1588	1589	-	-	I-NP	HYPH	O	22	NMOD	O
O	O	1589	1592	cis	cis	I-NP	NN	B-protein	22	NMOD	B-protein
O	O	1593	1595	RA	RA	I-NP	NN	I-protein	23	SUB	I-protein
O	O	1596	1603	induced	induce	B-VP	VBD	O	18	SBAR	O
T13	B-Protein	1604	1605	C	C	B-NP	NN	O	29	NMOD	O
T13	I-Protein	1605	1606	/	/	B-NP	SYM	O	29	NMOD	O
T13	I-Protein	1606	1609	EBP	EBP	I-NP	NN	B-RNA	29	NMOD	B-RNA
T13	I-Protein	1610	1617	epsilon	epsilon	I-NP	NN	I-RNA	29	NMOD	I-RNA
O	O	1618	1622	mRNA	mRNA	I-NP	NN	I-RNA	29	NMOD	I-RNA
O	O	1623	1635	accumulation	accumulation	I-NP	NN	O	23	OBJ	O
O	O	1636	1638	in	in	B-PP	IN	O	23	VMOD	O
O	O	1639	1642	the	the	B-NP	DT	O	32	NMOD	O
O	O	1643	1650	absence	absence	I-NP	NN	O	30	PMOD	O
O	O	1651	1653	of	of	B-PP	IN	O	32	NMOD	O
O	O	1654	1657	new	new	B-NP	JJ	O	36	NMOD	O
O	O	1658	1665	protein	protein	I-NP	NN	O	36	NMOD	O
O	O	1666	1675	synthesis	synthesis	I-NP	NN	O	33	PMOD	O
O	O	1675	1676	.	.	O	.	O	10	P	O

O	O	1677	1681	ATRA	ATRA	B-NP	NN	O	3	SUB	O
O	O	1682	1686	also	also	B-ADVP	RB	O	3	VMOD	O
O	O	1687	1694	induced	induce	B-VP	VBD	O	0	ROOT	O
O	O	1695	1705	expression	expression	B-NP	NN	O	3	OBJ	O
O	O	1706	1708	of	of	B-PP	IN	O	4	NMOD	O
T14	B-Protein	1709	1710	C	C	B-NP	NN	B-protein	10	NMOD	B-protein
T14	I-Protein	1710	1711	/	/	B-NP	SYM	I-protein	10	NMOD	I-protein
T14	I-Protein	1711	1714	EBP	EBP	I-NP	NN	I-protein	10	NMOD	I-protein
T14	I-Protein	1715	1722	epsilon	epsilon	I-NP	NN	I-protein	10	NMOD	I-protein
O	O	1723	1730	protein	protein	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	1731	1733	in	in	B-PP	IN	O	3	VMOD	O
O	O	1734	1737	NB4	NB4	B-NP	NN	B-cell_line	13	NMOD	B-cell_line
O	O	1738	1743	cells	cell	I-NP	NNS	I-cell_line	11	PMOD	I-cell_line
O	O	1743	1744	,	,	O	,	O	3	P	O
O	O	1745	1747	as	as	B-SBAR	IN	O	3	VMOD	O
O	O	1748	1753	shown	show	B-VP	VBN	O	15	SBAR	O
O	O	1754	1756	by	by	B-PP	IN	O	16	VMOD	O
O	O	1757	1764	Western	Western	B-NP	JJ	O	19	NMOD	O
O	O	1765	1773	blotting	blotting	I-NP	NN	O	17	PMOD	O
O	O	1773	1774	.	.	O	.	O	3	P	O

O	O	1775	1777	In	In	B-PP	IN	O	35	VMOD	O
O	O	1778	1786	contrast	contrast	B-NP	NN	O	1	PMOD	O
O	O	1787	1789	to	to	B-PP	TO	O	2	NMOD	O
O	O	1790	1793	the	the	B-NP	DT	O	5	NMOD	O
O	O	1794	1802	increase	increase	I-NP	NN	O	3	PMOD	O
O	O	1803	1805	of	of	B-PP	IN	O	5	NMOD	O
T15	B-Protein	1806	1807	C	C	B-NP	NN	B-protein	10	NMOD	B-protein
T15	I-Protein	1807	1808	/	/	B-NP	SYM	I-protein	10	NMOD	I-protein
T15	I-Protein	1808	1811	EBP	EBP	I-NP	NN	I-protein	10	NMOD	I-protein
T15	I-Protein	1812	1819	epsilon	epsilon	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	1820	1822	in	in	B-PP	IN	O	5	NMOD	O
O	O	1823	1824	9	9	B-NP	CD	O	11	PMOD	O
O	O	1824	1825	-	-	I-NP	HYPH	O	12	NMOD	O
O	O	1825	1828	cis	cis	I-NP	NN	O	15	NMOD	O
O	O	1829	1831	RA	RA	I-NP	NN	O	13	OBJ	O
O	O	1831	1832	-	-	B-VP	HYPH	O	15	NMOD	O
O	O	1832	1840	mediated	mediate	B-NP	VBN	O	19	NMOD	O
O	O	1841	1853	granulocytic	granulocytic	I-NP	JJ	O	19	NMOD	O
O	O	1854	1869	differentiation	differentiation	I-NP	NN	O	16	OBJ	O
O	O	1869	1870	,	,	O	,	O	35	P	O
O	O	1871	1874	the	the	B-NP	DT	O	25	NMOD	O
O	O	1875	1879	DMSO	DMSO	I-NP	NN	O	25	NMOD	O
O	O	1879	1880	-	-	B-NP	HYPH	O	25	NMOD	O
O	O	1880	1887	induced	induce	I-NP	VBN	O	25	NMOD	O
O	O	1888	1903	differentiation	differentiation	I-NP	NN	O	35	SUB	O
O	O	1904	1906	of	of	B-PP	IN	O	25	NMOD	O
O	O	1907	1909	HL	HL	B-NP	NN	B-cell_line	30	NMOD	B-cell_line
O	O	1909	1910	-	-	O	HYPH	I-cell_line	30	NMOD	I-cell_line
O	O	1910	1912	60	60	B-NP	CD	I-cell_line	30	NMOD	I-cell_line
O	O	1913	1918	cells	cell	I-NP	NNS	I-cell_line	26	PMOD	I-cell_line
O	O	1919	1923	down	down	B-PP	IN	O	25	NMOD	O
O	O	1924	1927	the	the	B-NP	DT	O	34	NMOD	O
O	O	1928	1940	granulocytic	granulocytic	I-NP	JJ	O	34	NMOD	O
O	O	1941	1948	pathway	pathway	I-NP	NN	O	31	PMOD	O
O	O	1949	1952	was	be	B-VP	VBD	O	0	ROOT	O
O	O	1953	1963	associated	associate	I-VP	VBN	O	35	VC	O
O	O	1964	1968	with	with	B-PP	IN	O	36	VMOD	O
O	O	1969	1971	an	an	B-NP	DT	O	40	NMOD	O
O	O	1972	1979	initial	initial	I-NP	JJ	O	40	NMOD	O
O	O	1980	1989	reduction	reduction	I-NP	NN	O	37	PMOD	O
O	O	1990	1992	of	of	B-PP	IN	O	40	NMOD	O
T16	B-Protein	1993	1994	C	C	B-NP	NN	B-RNA	46	NMOD	B-RNA
T16	I-Protein	1994	1995	/	/	B-NP	SYM	I-RNA	46	P	I-RNA
T16	I-Protein	1995	1998	EBP	EBP	I-NP	NN	I-RNA	46	NMOD	I-RNA
T16	I-Protein	1999	2006	epsilon	epsilon	I-NP	NN	I-RNA	46	NMOD	I-RNA
O	O	2007	2011	mRNA	mRNA	I-NP	NN	I-RNA	47	NMOD	I-RNA
O	O	2012	2018	levels	level	I-NP	NNS	O	41	PMOD	O
O	O	2018	2019	.	.	O	.	O	35	P	O

O	O	2020	2022	In	In	B-PP	IN	O	5	VMOD	O
O	O	2023	2030	summary	summary	B-NP	NN	O	1	PMOD	O
O	O	2030	2031	,	,	O	,	O	5	P	O
O	O	2032	2034	we	we	B-NP	PRP	O	5	SUB	O
O	O	2035	2039	have	have	B-VP	VBP	O	0	ROOT	O
O	O	2040	2050	discovered	discover	I-VP	VBN	O	5	VC	O
O	O	2051	2055	that	that	B-SBAR	IN	O	6	VMOD	O
O	O	2056	2066	expression	expression	B-NP	NN	O	15	SUB	O
O	O	2067	2069	of	of	B-PP	IN	O	8	NMOD	O
T17	B-Protein	2070	2071	C	C	B-NP	NN	B-RNA	14	NMOD	B-RNA
T17	I-Protein	2071	2072	/	/	B-NP	SYM	I-RNA	14	NMOD	I-RNA
T17	I-Protein	2072	2075	EBP	EBP	I-NP	NN	I-RNA	14	NMOD	I-RNA
T17	I-Protein	2076	2083	epsilon	epsilon	I-NP	NN	I-RNA	14	NMOD	I-RNA
O	O	2084	2088	mRNA	mRNA	I-NP	NN	I-RNA	9	PMOD	I-RNA
O	O	2089	2091	is	be	B-VP	VBZ	O	7	SBAR	O
O	O	2092	2100	markedly	markedly	I-VP	RB	O	15	VMOD	O
O	O	2101	2109	enhanced	enhance	I-VP	VBN	O	15	VC	O
O	O	2110	2112	as	as	B-PP	IN	O	17	VMOD	O
O	O	2113	2116	the	the	B-NP	DT	O	21	NMOD	O
O	O	2117	2120	NB4	NB4	I-NP	NN	B-cell_line	21	NMOD	B-cell_line
O	O	2121	2134	promyelocytes	promyelocyte	I-NP	NNS	I-cell_line	18	PMOD	I-cell_line
O	O	2135	2138	are	be	B-VP	VBP	O	5	VMOD	O
O	O	2139	2146	induced	induce	I-VP	VBN	O	22	VC	O
O	O	2147	2149	by	by	B-PP	IN	O	27	VMOD	O
O	O	2150	2159	retinoids	retinoid	B-NP	NNS	O	24	PMOD	O
O	O	2160	2162	to	to	B-VP	TO	O	27	VMOD	O
O	O	2163	2176	differentiate	differentiate	I-VP	VB	O	23	VMOD	O
O	O	2177	2184	towards	towards	B-PP	IN	O	27	VMOD	O
O	O	2185	2197	granulocytes	granulocyte	B-NP	NNS	B-cell_type	28	PMOD	B-cell_type
O	O	2197	2198	.	.	O	.	O	5	P	O

O	O	2199	2203	This	This	B-NP	DT	O	2	NMOD	O
O	O	2204	2213	induction	induction	I-NP	NN	O	10	SUB	O
O	O	2214	2216	of	of	B-PP	IN	O	2	NMOD	O
T18	B-Protein	2217	2218	C	C	B-NP	NN	B-RNA	8	NMOD	B-RNA
T18	I-Protein	2218	2219	/	/	B-NP	SYM	I-RNA	8	NMOD	I-RNA
T18	I-Protein	2219	2222	EBP	EBP	I-NP	NN	I-RNA	8	NMOD	I-RNA
T18	I-Protein	2223	2230	epsilon	epsilon	I-NP	NN	I-RNA	8	NMOD	I-RNA
O	O	2231	2235	mRNA	mRNA	I-NP	NN	I-RNA	9	NMOD	I-RNA
O	O	2236	2246	expression	expression	I-NP	NN	O	3	PMOD	O
O	O	2247	2249	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	2250	2267	transcriptionally	transcriptionally	I-VP	RB	O	10	VMOD	O
O	O	2268	2276	mediated	mediate	I-VP	VBN	O	10	VC	O
O	O	2277	2280	and	and	O	CC	O	10	VMOD	O
O	O	2281	2287	occurs	occur	B-VP	VBZ	O	10	VMOD	O
O	O	2288	2290	in	in	B-PP	IN	O	14	VMOD	O
O	O	2291	2294	the	the	B-NP	DT	O	17	NMOD	O
O	O	2295	2302	absence	absence	I-NP	NN	O	15	PMOD	O
O	O	2303	2305	of	of	B-PP	IN	O	17	NMOD	O
O	O	2306	2315	synthesis	synthesis	B-NP	NN	O	18	PMOD	O
O	O	2316	2318	of	of	B-PP	IN	O	19	NMOD	O
O	O	2319	2329	additional	additional	B-NP	JJ	O	20	PMOD	O
O	O	2330	2337	protein	protein	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	2338	2345	factors	factor	I-NP	NNS	I-protein	21	NMOD	I-protein
O	O	2345	2346	.	.	O	.	O	10	P	O

O	O	2347	2349	We	We	B-NP	PRP	O	2	SUB	O
O	O	2350	2357	suspect	suspect	B-VP	VBP	O	0	ROOT	O
O	O	2358	2362	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	2363	2366	the	the	B-NP	DT	O	11	NMOD	O
T19	B-Protein	2367	2368	C	C	I-NP	NN	B-DNA	11	NMOD	B-DNA
T19	I-Protein	2368	2369	/	/	B-NP	SYM	I-DNA	11	NMOD	I-DNA
T19	I-Protein	2369	2372	EBP	EBP	I-NP	NN	I-DNA	11	NMOD	I-DNA
T19	I-Protein	2373	2380	epsilon	epsilon	I-NP	SYM	I-DNA	11	NMOD	I-DNA
T20	B-Entity	2381	2389	promoter	promoter	I-NP	NN	I-DNA	11	NMOD	I-DNA
T20	I-Entity	2389	2390	/	/	I-NP	SYM	O	11	NMOD	O
T20	I-Entity	2390	2398	enhancer	enhancer	I-NP	NN	B-DNA	12	SUB	B-DNA
O	O	2399	2407	contains	contain	B-VP	VBZ	O	3	SBAR	O
O	O	2408	2409	a	a	B-NP	DT	O	18	NMOD	O
T21	B-Entity	2410	2418	retinoic	retinoic	I-NP	JJ	B-DNA	15	NMOD	B-DNA
T21	I-Entity	2419	2423	acid	acid	I-NP	NN	I-DNA	18	NMOD	I-DNA
T21	I-Entity	2423	2424	-	-	B-NP	HYPH	I-DNA	18	NMOD	I-DNA
T21	I-Entity	2424	2432	response	response	I-NP	NN	I-DNA	18	NMOD	I-DNA
T21	I-Entity	2433	2440	element	element	I-NP	NN	I-DNA	12	OBJ	I-DNA
O	O	2441	2445	that	that	B-NP	WDT	O	18	NMOD	O
O	O	2446	2448	is	be	B-VP	VBZ	O	19	SBAR	O
O	O	2449	2457	directly	directly	I-VP	RB	O	20	VMOD	O
O	O	2458	2468	stimulated	stimulate	I-VP	VBN	O	20	VC	O
O	O	2469	2471	by	by	B-PP	IN	O	22	VMOD	O
O	O	2472	2481	retinoids	retinoid	B-NP	NNS	O	23	PMOD	O
O	O	2481	2482	.	.	O	.	O	2	P	O
